Skip to main content

News and blog posts

03
Dec 2019

Scientific evidence on personalized population screening for breast cancer assessed by Spanish AQuAS

In October 2019, the Agency for Health Quality and Assessment of Catalonia (AQuAS) has released an assessment report regarding the scientific evidence on personalized population screening for breast cancer. The current evidence does not allow to recommend any concrete models for individualized risk prediction for breast cancer but allows to recommend the development and evaluation of new models for personalized risk prediction directed to offering different strategies to the screening of population.
03
Dec 2019

Med Tech-related technology assessments and clinical guidelines from NICE in October 2019

In October 2019, the National Institute for Health and Care Excellence (NICE) published one new interventional procedure guidance (for midcarpal hemiarthroplasty for wrist arthritis) and two new MedTech innovation briefings (for superDimension Navigation System to help diagnostic sampling of peripheral lung lesions and MR-proADM test for use with clinical deterioration scores in cases of suspected infection).
28
Nov 2019

MTRC is recruiting a Chinese analyst

MTRC is looking for a Chinese analyst to join our team. The responsibilities will include development and maintaining overviews of reimbursement systems in China and other Asian countries, development of reimbursement analysis, collection of cost data, payor and KOL interviews.
28
Nov 2019

MTRC is recruiting an Arab-speaking analyst

MTRC is looking for an Arab-speaking analyst to join our team. The responsibilities will include development and maintaining overviews of reimbursement systems in the Middle East countries, development of reimbursement analysis, collection of cost data, payor and KOL interviews.
26
Nov 2019

Cerenkov luminescence image projection system for cancer assessed by Spanish AQuAS

In October 2019, the Agency for Health Quality and Assessment of Catalonia (AQuAS) has released an assessment report regarding the evaluation of Сerenkov luminescence image projection system for intraoperative evaluation of surgical margins in breast, prostate and gastrointestinal cancer. This new technology is expected to get an improvement in the effectiveness of oncological surgery and a reduction in costs.
25
Nov 2019

Swedish recommendations for FoundationOne CDx genomic test by the New Therapies Council

The New Therapies (NT) Council provides comments on medical technology products and methods that are evaluated within the framework of the Dental and Pharmaceutical Benefits Agency (TLV) medical technology assignment. In October 2019, the NT Council recommended the use of FoundationOne CDx comprehensive genomic profiling test as support for the drug treatment choice in the context of clinical studies as there is a great need for knowledge and validation.